Exploring ketamine’s potential in the fight against treatment-resistant depression

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Eli Lilly’s partnership with Amazon to boost presence in diabetes and obesity markets – Pharmaceutical Technology

Share this article LillyDirect allows for online consultations and prescriptions, and Amazon delivers medicines to the patient’s home, offering fast delivery and discounts. Credit: Michael

March 19, 2024

Functional, nonepileptic seizures linked to higher death rate than expected

The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan

January 24, 2024

Innovative photodynamic therapy targets melanoma with light-activated dyes

Melanoma is one of the most aggressive skin cancers, with over 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has

February 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.